Search Results - "Stenzel, KH"

Refine Results
  1. 1

    Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients by Bologa, RM, Levine, DM, Parker, TS, Cheigh, JS, Serur, D, Stenzel, KH, Rubin, AL

    Published in American journal of kidney diseases (01-07-1998)
    “…Low serum albumin and low serum cholesterol levels are among the most consistent predictors of mortality in patients with end-stage renal disease (ESRD)…”
    Get full text
    Journal Article
  2. 2

    Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure by Chertow, G M, Burke, S K, Lazarus, J M, Stenzel, K H, Wombolt, D, Goldberg, D, Bonventre, J V, Slatopolsky, E

    Published in American journal of kidney diseases (01-01-1997)
    “…Dietary phosphate restriction and the oral administration of calcium and aluminum salts have been the principal means of controlling hyperphosphatemia in…”
    Get more information
    Journal Article
  3. 3

    Selective effects of TPA and IL-1 on protein phosphorylation in murine thymocytes by Avissar, S, Stenzel, K H, Novogrodsky, A

    Published in Cellular immunology (01-12-1985)
    “…Protein kinase C activity was demonstrated in murine thymocytes and the effects of TPA and IL-1 on this enzyme were studied. TPA, but not IL-1, could…”
    Get more information
    Journal Article
  4. 4

    Neutralization of Endotoxin by a Phospholipid Emulsion in Healthy Volunteers by Gordon, Bruce R., Parker, Thomas S., Levine, Daniel M., Feuerbach, Fred, Saal, Stuart D., Sloan, Betty-Jane, Chu, Cindy, Stenzel, Kurt H., Parrillo, Joseph E., Rubin, Albert L.

    Published in The Journal of infectious diseases (01-05-2005)
    “…BackgroundAn approach to endotoxin (lipopolysaccharide [LPS]) blockade makes use of the ability of lipoproteins, via surface phospholipids, to bind and…”
    Get full text
    Journal Article
  5. 5

    Regulation of new DNA synthesis in mammalian cells by cyclosporine. Demonstration of a transforming growth factor beta-dependent mechanism of inhibition of cell growth by Khanna, A, Li, B, Stenzel, K H, Suthanthiran, M

    Published in Transplantation (27-02-1994)
    “…Immunosuppressants such as cyclosporine are considered to constrain cell growth by preventing the production of growth stimulatory cytokines (e.g.,…”
    Get more information
    Journal Article
  6. 6

    Differential regulation of transforming growth factor β and interleukin 2 genes in human T cells : demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction by LI, B, SEHAJPAL, P. K, KHANNA, A, VLASSARA, H, CERAMI, A, STENZEL, K. H, SUTHANTHIRAN, M

    Published in The Journal of experimental medicine (01-11-1991)
    “…The regulation of mRNA encoding transforming growth factor beta (TGF-beta) and interleukin 2 (IL-2) in normal human T cells was explored using novel competitor…”
    Get full text
    Journal Article
  7. 7

    Hypertension is not adequately controlled in hemodialysis patients by Cheigh, J S, Milite, C, Sullivan, J F, Rubin, A L, Stenzel, K H

    Published in American journal of kidney diseases (01-05-1992)
    “…To examine the adequacy of hypertension control, we monitored the blood pressure (BP) of 53 hemodialysis patients who received treatment for hypertension. BP…”
    Get more information
    Journal Article
  8. 8

    Safety and Pharmacokinetics of an Endotoxin-Binding Phospholipid Emulsion by Gordon, Bruce R, Parker, Thomas S, Levine, Daniel M, Saal, Stuart D, Hudgins, Lisa Cooper, Sloan, Betty-Jane, Chu, Cindy, Stenzel, Kurt H, Rubin, Albert L

    Published in The Annals of pharmacotherapy (01-07-2003)
    “…BACKGROUND: Lipids and lipoproteins have been shown to bind and neutralize endotoxin and to improve outcomes in animal models of sepsis. OBJECTIVE: To provide…”
    Get full text
    Journal Article
  9. 9

    End-stage renal disease in systemic lupus erythematosus by Cheigh, J S, Stenzel, K H

    Published in American journal of kidney diseases (01-01-1993)
    “…The progression of lupus nephritis severe enough to require dialysis does not necessarily indicate that it is "end-stage." Ten percent to 28% of patients with…”
    Get more information
    Journal Article
  10. 10

    Intragraft expression of IL-10 messenger RNA: A novel correlate of renal allograft rejection by Xu, Guo-Ping, Sharma, Vijay K., Li, Baogui, Bologa, Roxana, Li, Yi, Mouradian, Janet, Wang, John, Serur, David, Rao, Venkateswara, Stenzel, Kurt H., Suthanthiran, Manikkam

    Published in Kidney international (01-11-1995)
    “…Intragraft expression of IL-10 messenger RNA: A novel correlate of renal allograft rejection. A major conceptual advance is the formulation that type I…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    Immune stimulatory properties of metalloporphyrins by Novogrodsky, A, Suthanthiran, M, Stenzel, KH

    Published in The Journal of immunology (1950) (15-12-1989)
    “…A possible approach to the immunotherapy of tumors is to stimulate either specific or nonspecific immune responses in vivo. We recently found that provision of…”
    Get full text
    Journal Article
  12. 12

    Synergism between the CD3 antigen- and CD2 antigen-derived signals. Exploration at the level of induction of DNA-binding proteins and characterization of the inhibitory activity of cyclosporine by Sehajpal, P K, Sharma, V K, Ingulli, E, Stenzel, K H, Suthanthiran, M

    Published in Transplantation (01-05-1993)
    “…We have demonstrated earlier that the crosslinkage of the CD3/TCR complex with the CD2 antigen results in the proliferation of normal human T cells. The effect…”
    Get more information
    Journal Article
  13. 13

    Effect of polar organic compounds on leukemic cells. Butyrate-induced partial remission of acute myelogenous leukemia in a child by Novogrodsky, A, Dvir, A, Ravid, A, Shkolnik, T, Stenzel, K H, Rubin, A L, Zaizov, R

    Published in Cancer (01-01-1983)
    “…Polar organic compounds, such as dimethylsulfoxide and butyric acid, are known to induce differentiation in Friend erythroleukemia cells as well as in other…”
    Get more information
    Journal Article
  14. 14

    Immune stimulatory and anti‐tumour properties of haemin by TSUJI, A., WANG, J., STENZEL, K. H., NOVOGRODSKY, A.

    Published in Clinical and experimental immunology (01-09-1993)
    “…SUMMARY IL‐2 induces tumour regression in some patients with metastatic disease, but the dose of IL‐2 is limited by severe toxicity. Agents that increase the…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival by Cheigh, J S, Haschemeyer, R H, Wang, J C, Riggio, R R, Tapia, L, Stenzel, K H, Rubin, A L

    Published in American journal of hypertension (01-05-1989)
    “…To examine the effects of hypertension on renal graft function, we studied the clinical course of 144 kidney transplant recipients who had functioning grafts…”
    Get more information
    Journal Article
  17. 17

    Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols by Suthanthiran, M, Haschemeyer, R H, Riggio, R R, Adubor, C, Friedman, G S, Cheigh, J S, Wang, J C, Fotino, M, Stubenbord, W T, Saal, S D

    Published in Transplantation (01-05-1993)
    “…Many transplant centers routinely utilize monoclonal antibody or polyclonal antibody based induction protocols in recipients of cadaver renal allografts. Given…”
    Get more information
    Journal Article
  18. 18

    Hydroxyl radical scavengers inhibit human natural killer cell activity by Suthanthiran, M, Solomon, S D, Williams, P S, Rubin, A L, Novogrodsky, A, Stenzel, K H

    Published in Nature (London) (01-01-1984)
    “…As natural killer (NK) cell activity is an essential constituent of host defence systems and reactive oxygen intermediates participate in such defence, the…”
    Get full text
    Journal Article
  19. 19

    OKT3-associated adverse reactions: mechanistic basis and therapeutic options by Suthanthiran, M, Fotino, M, Riggio, R R, Cheigh, J S, Stenzel, K H

    Published in American journal of kidney diseases (01-11-1989)
    “…OKT3, a prototypic monoclonal antibody directed at the lineage-specific CD3 antigen expressed on mature T cells, is an effective immunosuppressant in organ…”
    Get more information
    Journal Article
  20. 20

    Impact of renal donation. Long-term clinical and biochemical follow-up of living donors in a single center by Miller, I J, Suthanthiran, M, Riggio, R R, Williams, J J, Riehle, R A, Vaughan, E D, Stubenbord, W T, Mouradian, J, Cheigh, J S, Stenzel, K H

    Published in The American journal of medicine (01-08-1985)
    “…Forty-six renal donors who responded to a questionnaire and two additional donors with nephrotic syndrome and renal insufficiency were studied. The mean age…”
    Get more information
    Journal Article